Similar articles for PMID: 21774881

Year	Number of Results
2005	2
2008	2
2009	6
2010	4
2011	4
2012	10
2013	5
2014	6
2015	6
2016	9
2017	7
2018	12
2019	10
2020	14
2021	7
2022	3
2023	7
2024	1

1

Impact of venous thromboembolism on clinical management and therapy after hip and knee arthroplasty.

Fisher WD. Fisher WD. Can J Surg. 2011 Oct;54(5):344-51. doi: 10.1503/cjs.007310. Can J Surg. 2011. PMID: 21774881 Free PMC article. Review.

2

Rivaroxaban and dabigatran etexilate: two new oral anticoagulants for extended postoperative prevention of venous thromboembolism after elective total hip arthroplasty.

Borris LC. Borris LC. Arch Orthop Trauma Surg. 2010 May;130(5):583-9. doi: 10.1007/s00402-009-0930-9. Epub 2009 Jun 30. Arch Orthop Trauma Surg. 2010. PMID: 19565250

3

Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty.

Levitan B, Yuan Z, Turpie AG, Friedman RJ, Homering M, Berlin JA, Berkowitz SD, Weinstein RB, DiBattiste PM. Levitan B, et al. Vasc Health Risk Manag. 2014 Mar 26;10:157-67. doi: 10.2147/VHRM.S54714. eCollection 2014. Vasc Health Risk Manag. 2014. PMID: 24707185 Free PMC article.

4

Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair.

Forster R, Stewart M. Forster R, et al. Cochrane Database Syst Rev. 2016 Mar 30;3(3):CD004179. doi: 10.1002/14651858.CD004179.pub2. Cochrane Database Syst Rev. 2016. PMID: 27027384 Free PMC article. Review.

5

Effectiveness and safety of rivaroxaban for the prevention of thrombosis following total hip or knee replacement: A systematic review and meta-analysis.

Liu J, Zhao J, Yan Y, Su J. Liu J, et al. Medicine (Baltimore). 2019 Mar;98(9):e14539. doi: 10.1097/MD.0000000000014539. Medicine (Baltimore). 2019. PMID: 30817570 Free PMC article.

6

Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study.

Yhim HY, Lee J, Lee JY, Lee JO, Bang SM. Yhim HY, et al. PLoS One. 2017 May 24;12(5):e0178214. doi: 10.1371/journal.pone.0178214. eCollection 2017. PLoS One. 2017. PMID: 28542415 Free PMC article.

7

Incidence of symptomatic venous thromboembolism in 2372 knee and hip replacement patients after discharge: data from a thromboprophylaxis registry in Montreal, Canada.

Senay A, Trottier M, Delisle J, Banica A, Benoit B, Laflamme GY, Malo M, Nguyen H, Ranger P, Fernandes JC. Senay A, et al. Vasc Health Risk Manag. 2018 May 8;14:81-89. doi: 10.2147/VHRM.S150474. eCollection 2018. Vasc Health Risk Manag. 2018. PMID: 29780248 Free PMC article.

8

Factor Xa Inhibitors and Direct Thrombin Inhibitors Versus Low-Molecular-Weight Heparin for Thromboprophylaxis After Total Hip or Total Knee Arthroplasty: A Systematic Review and Meta-Analysis.

Sun G, Wu J, Wang Q, Liang Q, Jia J, Cheng K, Sun G, Wang Z. Sun G, et al. J Arthroplasty. 2019 Apr;34(4):789-800.e6. doi: 10.1016/j.arth.2018.11.029. Epub 2018 Dec 1. J Arthroplasty. 2019. PMID: 30685261

9

Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal.

Stevenson M, Scope A, Holmes M, Rees A, Kaltenthaler E. Stevenson M, et al. Health Technol Assess. 2009 Oct;13 Suppl 3:43-8. doi: 10.3310/hta13suppl3/07. Health Technol Assess. 2009. PMID: 19846028 Free article. Review.

10

Effect of Aspirin vs Enoxaparin on Symptomatic Venous Thromboembolism in Patients Undergoing Hip or Knee Arthroplasty: The CRISTAL Randomized Trial.

CRISTAL Study Group; Sidhu VS, Kelly TL, Pratt N, Graves SE, Buchbinder R, Adie S, Cashman K, Ackerman I, Bastiras D, Brighton R, Burns AWR, Chong BH, Clavisi O, Cripps M, Dekkers M, de Steiger R, Dixon M, Ellis A, Griffith EC, Hale D, Hansen A, Harris A, Hau R, Horsley M, James D, Khorshid O, Kuo L, Lewis P, Lieu D, Lorimer M, MacDessi S, McCombe P, McDougall C, Mulford J, Naylor JM, Page RS, Radovanovic J, Solomon M, Sorial R, Summersell P, Tran P, Walter WL, Webb S, Wilson C, Wysocki D, Harris IA. CRISTAL Study Group, et al. JAMA. 2022 Aug 23;328(8):719-727. doi: 10.1001/jama.2022.13416. JAMA. 2022. PMID: 35997730 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year